Question

What is the best country for stem cell therapy for Muscular Dystrophy?

There is no evidence-based best country. Prioritise a verified neuromuscular centre, exact authorised product or trial, genetic eligibility, cardiac and respiratory capability, manufacturing traceability and long-term monitoring.

Medical review statusPending clinical sign-offLast evidence update: 2026-08-05Methodology and editorial standards
Clinical review team: Dr Kamelia Milcheva, Hematologist · Dr Vadym Uvarov, Board-Certified Physician · Hepatobiliary Surgeon · Candidate of Medical SciencesEditorial responsibility: StemCellAtlas research teamEducational information only. This page does not provide medical advice, diagnosis or a treatment recommendation.

The cost picture for Muscular Dystrophy

Do not compare an advertised cell package with gene-targeted therapy or multidisciplinary care by headline price. Itemise genetic confirmation, product, administration, cardiac and respiratory monitoring, immunosuppression where applicable, travel, follow-up and complication care. Preserve access to established neuromuscular, respiratory, cardiac, orthopaedic and rehabilitation services.

Am I a candidate? → · Muscular Dystrophy: full overview → · Muscular Dystrophy cost → · Cost →

Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.

Sources & further reading

Explore all sections · Data & downloads

Compare cell-therapy evidence, registered studies and published price observations.

StemCellAtlas is a source-first research and cost-planning guide. It separates registry and regulator evidence from heterogeneous commercial observations.

Request written information